Tag: EpiPen
Pharmaceuticals and HME: No parity
August 25, 2016Theresa Flaherty, Managing Editor
Things have been tough for the HME community for the past few years but this summer has taken it to a whole 'nother level. Not only has the Medicare reimbursement for DME been decimated, other payers have begun to follow suit.
AAHomecare has tasked itself with gathering anecdotes about the impact on businesses as well as beneficiaries and I know I've heard my own share of horror stories. The best thing providers can do right now, say stakeholders, is amplify that message.
Meanwhile, over in the fantasyland...